Patients, Researchers & Advocacy Groups Celebrate Historic Prop 38 Victory to Develop Life-Saving Medical Research
News originally published by
EIN PresswireVoters Approve $8.4 Billion Bond to Accelerate Breakthrough Treatments and Cures for Cancer, Alzheimer’s, Parkinson’s, ALS and Other Devastating Diseases
Twenty years ago, I didn’t know if I would live to see my six-year-old son grow up. Now voters have given countless other patients the hope that the next breakthrough will come in time for them, too.”
SACRAMENTO, CA, UNITED STATES, November 9, 2026 /EINPresswire.com/ -- In a major victory for millions of patients and families affected by devastating diseases, California voters have approved Proposition 38, the Immunology Medical Research & Cures Initiative, providing vitally needed funding to accelerate research into breakthrough treatments and cures for cancer, Alzheimer’s, Parkinson’s, heart disease, ALS, multiple sclerosis and other debilitating diseases. The historic investment offers new hope to patients waiting for life-saving medical advances and the chance for more years with the people they love.— Laurie Adami, cancer survivor
“This victory belongs to the patients and families who have spent years fighting devastating diseases and waiting for the next medical breakthrough,” said Chris Tarver, R.N., President of the American Nurses Association\California.
The measure will fund a statewide network of researchers, universities and nonprofit institutions working to advance immunology discoveries and turn promising science into life-saving treatments. Its passage comes as federal research funding cuts have disrupted clinical trials and delayed medical discoveries nationwide.
“Immunology holds enormous promise for new treatments and cures to help those living with conditions like blood cancer,” said Adam Zarrin, director of state government affairs at Blood Cancer United. “With the passage of Prop 38, California has reaffirmed its commitment to science, and to expanding access to bringing those life-saving breakthroughs to patients and families here at home and around the world.”
For Los Angeles cancer survivor Laurie Adami, immunotherapy's promise is personal. After battling stage IV lymphoma for 12 years, she received CAR T-cell therapy through a clinical trial in 2018 and has been in complete remission since.
“Thanks to the voters for passing Prop 38 to accelerate medical research to save lives. I’m alive today because researchers developed an immunotherapy that saved my life,” said Adami, a board member of Blood Cancer United Greater Los Angeles. “Twenty years ago, I didn’t know if I would live to see my six-year-old son grow up. Now, California voters have given countless other patients the hope that the next breakthrough will come in time for them, too. I’m living proof that investing in research saves lives.”
Los Angeles resident Viva Mogi is a caregiver to her mother, who has Alzheimer’s. She is one of nearly 7 million Californians caring for a loved one, and they want one thing above all: better treatments and cures in our lifetime.
“When you’re caring for someone you love, you don’t just think about the cost, only more time,” said Mogi. “What keeps me going is the hope that new treatments will come soon enough to make a real difference for the millions of families who this devastating disease will impact. Prop 38 is about giving researchers the resources to make that happen.”
A broad coalition of doctors, nurses, scientists, patient advocates and more than 100 organizations endorsed Prop 38, including The Michael J. Fox Foundation for Parkinson’s Research, ALS Association, Alzheimer’s Association, American Nurses Association\California, Blood Cancer United, and National Multiple Sclerosis Society.
For more information, visit YESon38.com.
Robin Swanson
YES on Prop 38
Visit us on social media:
LinkedIn
Instagram
Facebook
X
Other
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
